CFO
VictoryShares US 500 Enhanced Volatility Wtd ETF
stock NASDAQ ETF

I’m gonna hold my short position. Sanjay and the CFO are speaking at Goldman on Thursday. Hope it sinks in over drinks 🍹

I'm with you. Time for some fresh takes. Might not be a Lisa problem. Maybe more of the c suite needs to follow CFO....

Maybe the number had gone down right at the end of the quarter due to hedgies' manipulation of DRS numbers, so they waited it out until the number increased. Maybe they wanted to be able to report that approx 25% of shares are directly registered so they had to wait until that number crossed the 75.5M threshold. Maybe their CFO got sick and hadn't been able to review it. Who knows.
I'm just saying we shouldn't draw conclusions from unknowns. Speculation is all good fun but when people are misquoting the actual filing and those posts ~~are~~ were on the top of the sub, that is a problem. Mods seem to be cracking down on that now

crater in the middle of the prophesied 2025 "AI" boom per MU CFO remarks.

A lot of trending posts are unequivocally stating that the DTC, DTCC, and/or Cede & Co. is/are the source(s) of the number of shares that are held in the name of Cede & Co as reported in the 10-k. Let's first look at the only mention of Cede & Co. within the 10-K:
> Our Class A Common Stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “GME”. As of March 22, 2023, there were 197,058 record holders of our Class A Common Stock. **Excluding the approximately 228.7 million shares of our Class A Common Stock held by Cede & Co on behalf of the Depository Trust & Clearing Corporation (or approximately 75% of our outstanding shares)**, approximately 76.0 million shares of our Class A Common Stock were held by record holders as of March 22, 2023 (or approximately 25% of our outstanding shares).
[Source.](https://news.gamestop.com/static-files/f4494fbe-9752-4056-a3c7-451f0cf9a668) (emphasis added)
So the (multiple choice) question is: who reported Cede & Co as being the holder of 228.7 million shares?
A.) that data is from Cede & Co, DTC, or DTCC
B.) that data is from GameStop
C.) that data is from DTC
If you read most of the hot posts about this, you'd think the answer is A. But where does it say that? It doesn't. If that were the case, Gamestop would/should have said something along the lines of "According to the DTCC" or "As reported by Cede & Co," yet it is completely silent as to the source of that data so the answer is B.
The 10-k is Gamestop's report. And unless stated otherwise, Gamestop is the source of the information or is adopting the information as true. That is because Gamestop cannot legally mislead investors or include any information that is materially false. [Source](https://www.sec.gov/answers/reada10k.htm) ("The company writes the 10-K and files it with the SEC. Laws and regulations prohibit companies from making materially false or misleading statements in their 10-Ks. Likewise, companies are prohibited from omitting material information that is needed to make the disclosure not misleading. In addition, as noted above, the Sarbanes-Oxley Act requires a company’s CFO and CEO to certify the accuracy of the 10-K.")
Accordingly, if the data was from the DTC, DTCC, or Cede & Co AND Gamestop knew it was false, it could not legally report it as it did. It would have to include a qualifier, such as "According to the DTCC, Cede & Co is the holder of 228.7 million shares." This would be a true statement even if Gamestop knew that such a number was inaccurate because it is only stating what was reported by another entity and not vouching for the veracity of such a statement. (Although, if I'm the lawyer advising on this, I'd say they'd have to go a step further and include a disclaimer that they are not representing that such data is accurate and are including it only as reported by the DTC and without verification).
Because Gamestop reported the numbers without any qualifiers, the only conclusion we can draw is that Gamestop believes that number is correct as it would be in breach of a myriad of laws and regulations if it did not.
So why is the baseless conclusion that "Cede & Co is the source of the data" being pushed? I believe that it is being pushed because it is accompanied by the conclusion that DRS numbers are much higher than actually reported. This conclusion is erroneous for the same reasons as above (i.e. Gamestop cannot report information it knows to be false). And it is a dangerous conclusion for us to make because it decreases the motivation to DRS by encouraging [social loafing](https://en.m.wikipedia.org/wiki/Social_loafing).

WhY DrS whEN wE aLrEADdy HAvE mOrE tHAn eNoUgH sHaReS rEgIsTeREd?
The truth as we know it and as reported by Gamestop is that we have DRS'd about 25% of the shares outstanding. Becuase no other source is cited, that information is either from Gamestop or adopted by Gamestop as true (e.g. from Computershare and then adopted by Gamestop in the 10k). This is a huge accomplishment, and it should not be downplayed with baseless conclusions. The truth is our best friend and the worst enemy of the hedgies and their Mayo Overlord.
BUY, HODL, SHOP, AND DRS!!

I think the OP mentioned that CEO/new CFO (something along those lines) made some insider purchases and the stock has started to rebound.

Yeah, I dont think a tenured CFO would off himself over a simple lawsuit. It would have been just another Tuesday for him. Anyway, I'm not interested in selling not at $27, what more at current prices. Will probably grab more at a discount.

Goldman Sachs just fired their board of directors, CEO and CFO including auditors which saves around a $2 billion in salary and bonus.
Subscribed to ChatGPT 4 Premium

Hey are you guys following any of the cannabis community stocks lately? I wanted to share with you my DD on Avicanna Inc. (AVCNF). As we all know, the cannabis industry has been growing rapidly over the past few years, and Avicanna is one of the companies that has been making waves in this space. Avicanna is a Canadian company that focuses on developing and commercializing plant-derived cannabinoid-based products for various medical conditions. With that being said, let's dive into the details and see what makes Avicanna a promising investment opportunity.
​
https://preview.redd.it/gp0r68akyoqa1.png?width=452&format=png&auto=webp&v=enabled&s=32d7d6efb380666dc762533213bb9cd8b4e71ee5
**Summary**
Avicanna is a Canadian biopharmaceutical company that specializes in developing and commercializing plant-derived cannabinoid-based products for various medical conditions. The company has a diverse portfolio of products, including topical creams, oils, and capsules, among others. Avicanna's products are designed to target a range of medical conditions, including chronic pain, anxiety, and sleep disorders, among others.
Avicanna has made significant progress in developing its products, and the company has been granted several patents for its innovations in cannabinoid-based therapies. Avicanna also has partnerships with leading research institutions, which allows the company to stay at the forefront of cannabinoid research and development.
**Leadership Team and Company Profile**
​
https://preview.redd.it/ztpdr37lyoqa1.png?width=204&format=png&auto=webp&v=enabled&s=f20d1c309b059018b8a0f1a38bacf4d2fdc54fd9
https://preview.redd.it/yjnr2nulyoqa1.png?width=216&format=png&auto=webp&v=enabled&s=ff49c1702efafbed45c3c97f70bb9f3d4ee9d3da
Avicanna Inc. (AVCNF) has a talented leadership team that has a strong track record of success in the biopharmaceutical industry.
Aras Azadian, the CEO and co-founder of Avicanna, has over 10 years of experience in the cannabis industry. Phillip Cardella, CPA, CA is the current CFO of Avicanna. He has extensive experience from MNP LLP, where he managed and advised new companies and served as audit lead for Avicanna.
Phillip ensures the accuracy and reliability of Avicanna's financials and provides sound financial management. Dr. Frantz Le Dévédec, PhD is Avicanna's EVP of Research & Product Development, with 15+ years of experience in biomaterials and drug delivery systems. His expertise in translational sciences has been pivotal in Avicanna's evolution, with an industry-leading scientific platform and pipeline of proprietary products. He established their industrial process in Colombia and represents the company internationally.
The company is headquartered in Toronto, Canada, and has operations in both Canada and Colombia. Avicanna's Colombian operations give the company a competitive advantage, as it allows them to access low-cost, high-quality cannabis biomass for their products. Additionally, Avicanna has a strategic partnership with the University of Toronto, which provides the company with access to world-class research facilities and talent.
**Financials**
In terms of financials, Avicanna has been steadily growing its revenue over the past few years. In 2020, the company reported revenue of $4.4 million, up from $1.4 million in 2019. Avicanna has also been able to reduce its net losses, reporting a net loss of $12.3 million in 2020, down from $22.5 million in 2019.
Avicanna has a healthy balance sheet, with total assets of $44.5 million and total liabilities of $16.9 million as of December 31, 2020. The company also has a strong cash position, with cash and cash equivalents of $22.6 million as of December 31, 2020.
**Highlighted Main Points**
• Avicanna is a Canadian biopharmaceutical company that specializes in developing and commercializing plant-derived cannabinoid-based products for various medical conditions.
• The company has a diverse portfolio of products, including topical creams, oils, and capsules, among others.
• Avicanna has been granted several patents for its innovations in cannabinoid-based therapies and has partnerships with leading research institutions.
• The company reported revenue of $4.4 million in 2020, up from $1.4 million in 2019, and has a strong cash position with $22.6 million in cash and cash equivalents as of December 31, 2020.
**Recent News:**
Shoppers Drug Mart partners with Avicanna to transition Medical Cannabis by Shoppers: https://ca.finance.yahoo.com/news/shoppers-drug-mart-partners-avicanna-115000943.html
Avicanna Announces Closing of Non-Brokered Private Placement: https://ca.finance.yahoo.com/news/avicanna-announces-closing-non-brokered-113000689.html
**Conclusion**
Overall, Avicanna Inc. (AVCNF) is a promising investment opportunity for those looking to invest in the cannabis industry. The company has a diverse portfolio of products, a strong focus on research and development, and a healthy balance sheet. Avicanna's commitment to innovation and its partnerships with leading research institutions make it a company to watch in the coming years.
*Disclaimer: Always remember to do you own DD, this is not financial advice*
Check out **Avicanna (**[**AVCN.TO**](https://AVCN.TO)**)**

Less than 30 days until INTC's next big earnings miss. I've never seen a CEO/CFO so out of touch with how the business is performing. Its like the first time they are seeing the numbers is on the earnings call.

I don’t understand how these billionaires can get caught. Meanwhile the millionaire CFO from wirecard escaped Germany, to be never seen again.

Didn't they replace the CFO? Could this be because each financial officer uses distinct language? Love the hype, but gotta play devil's advocate.

GM WSB,
TL;DR - Feels like deja-vu, but the spotlight is once again on Oil with Buffett and Icahn buying more of $OXY and $SWX, respectively. Total insider trading activity declined this week, with \~50% declines in both purchases, sales, and insiders submitting Form 4 filings from the prior week.
The major drop in Consumer Staples is due to the Walton’s selling a small percentage of shares. They do this on a regular basis and are likely rewarded more through stock options. Nothing worth investigating IMO.
Interestingly, the Financials sector didn’t catch a bid in the Banking sector, unlike [last week](https://www.reddit.com/r/wallstreetbets/comments/11yjo3n/insider_trading_weekly_update_031_another_buffett/). I haven’t checked the performance of regional banks yet, though given that the economy hasn’t imploded \*yet\*, I wouldn’t be surprised to see if they are experiencing some upside.
Finally - what is going on with Icahn and SWX? He is arguably the most notorious activist investor, and this is the 3rd week in a row where he’s increased his position. Seems like there might be something brewing - but please don't take my word for it. DYOR.
# Below are some notable sales from insiders:
* Softbank’s Vision Fund decreased their stake in Roviant Sciences ($ROIV / Biotechnology) by 12.63% with a $96M sale on March 20th
* Jeffrey Williams, the **COO of Apple** ($AAPL / Technology Hardware), decreased his stake by 27.71% with a $30M sale on March 22nd
* Stanley Tang, a Director at Doordash ($DASH / Internet & DIrect Marketing Retail), liquidated his entire position with an $11M sale on March 20th
* Benoit Dageville, the President of Products at Snowflake ($SNOW / IT Services), decreased his stake by 57.37% with a $8.2M sale on March 22nd
* Martine Rothblatt, the CEO of United Therapeutics ($UTHR / Biotechnology), sold her entire position in a $3.5M sale on March 20th
# And some notable buys from insiders:
* Warren Buffett purchased an additional $216M of Occidental Petroleum ($OXY / Oil, Gas & Consumable Fuels) on March 23rd, increasing his stake by 1.76%
* Carl Icahn increased his stake in Southwest Gas Holdings ($SWX / Gas Utilities) by 5.21% with a $30.4M purchase on March 22nd
* Chen Bihua, a 10% Owner of Moonlake Immunotherapeutics ($MLTX / Biotechnology), increased his stake by 29.02% with a $16.7M purchase on March 20th
* Joseph Steinberg, a Director at Vitesse Energy ($VTS / Oil, Gas & Consumable Fuels) purchased $2.68M worth of shares on March 22nd, increasing his stake by 48.02%
* Edward Shoen, the President of U-Haul ($UHAL / Road & Rail) purchased a stake in the firm for $1.4M on March 23rd
* Lindy Harty, a Director at CHart Industries ($GTLS / Machinery), increased her stake by 468% with a $525K purchase on March 20th
# High-Level Stats:
* Purchases decreased from $643M to $311M (-52%)
* Sales decreased from $2.1B to $1.2B (-46%)
* Transactions decreased from 990 to 401 (-59%)
* Companies represented in Form 4s decreased from 477 to 220 (-54%)
* Net buyers decreased from 156 to 47 (-70%)
* Net sellers decreased from 321 to 173 (-46%)
* Insiders filing Form 4s decreased from 861 to 352 (-59%)
* Net buyers decreased from 271 to 68 (-75%)
* Net sellers decreased from 590 to 284 (-52%)
# Transaction Selection
1. **All** **Open Market Transactions** from **March 20th - March 24th.** These are Form 4 filings with a Transaction Code of “P” or “S”. This narrows the scope to trades where insiders are putting their money on the line.
2. **Both indirect and direct** transactions are included in the reports.
3. Weekly comparisons are to transactions from **March 13th - March 17th.**
4. **No companies without a ticker**
5. No penny stocks or banned tickers.
# Further Context
1. Form 4 data is impacted by a concept known as **backfill** which is par for the course with transactional data. The delay between the Filing Date and the Transaction Date is **\*roughly\*** 2 days and your mileage will vary. This means that **more transactions for past dates can arrive in future filings.** That is why looking at larger trends is key.
2. To combat backfill, filings through this Tuesday are included **\*if\*** the transaction date is from the prior week. Otherwise, transactions from this week are excluded.
3. Data is sourced by algos behind[ Form Fore](http://formfore.io/)
# 1. Market Sector
https://preview.redd.it/hyp97f8shoqa1.png?width=1243&format=png&auto=webp&v=enabled&s=14c24abf7cc6cb15f499487412d24d73d2d76856
https://preview.redd.it/5argve8shoqa1.png?width=1238&format=png&auto=webp&v=enabled&s=5eeaef77521f39200e835466f2376691a845a43e
https://preview.redd.it/54s5pg8shoqa1.png?width=1238&format=png&auto=webp&v=enabled&s=eeb2ee4a0769f63cc16fb63037659bb9e4f4f5de
https://preview.redd.it/wji83j8shoqa1.png?width=1237&format=png&auto=webp&v=enabled&s=5814cb75ed934dbcbfdf72027be7fe4e94dfc484
# 2. Market Cap
https://preview.redd.it/tc8zi1wrhoqa1.png?width=1244&format=png&auto=webp&v=enabled&s=6cd72cd705984f3a1b0ed189aa0d5874b53d08c8
https://preview.redd.it/voc6v2wrhoqa1.png?width=1229&format=png&auto=webp&v=enabled&s=a5a4a0c6809d24afef33d23f2fca0cb6df90b094
https://preview.redd.it/0vvisbwrhoqa1.png?width=1233&format=png&auto=webp&v=enabled&s=553813b7ab08915b5bcfa2f8c42af0a5e23b6149
https://preview.redd.it/btkzddwrhoqa1.png?width=1228&format=png&auto=webp&v=enabled&s=baccbbb6b41a06e1cc7be247e55f172c1b03df20
# 3. Dollar Value of Transactions
https://preview.redd.it/uzhuoelvhoqa1.png?width=933&format=png&auto=webp&v=enabled&s=54b6c8a5de959549ece51ba4f4a4a103be651e29
# 4. Transaction Counts
https://preview.redd.it/iid2u64vhoqa1.png?width=925&format=png&auto=webp&v=enabled&s=8ab7d484a4b9d9e515f3ed9ceee07ee58a4d9e51
# 5. Top 10 Transactions by Category
https://preview.redd.it/6vi11fruhoqa1.png?width=923&format=png&auto=webp&v=enabled&s=69e92942f0a7871fb3d4ed517f23cf7cb5039caf
# Top CEO/CFO Purchases
https://preview.redd.it/4j568dcuhoqa1.png?width=922&format=png&auto=webp&v=enabled&s=201a173a9da3246a80fc64bfd8db27646642c02f
# Top 10% Owner Purchases
https://preview.redd.it/otk4haxthoqa1.png?width=922&format=png&auto=webp&v=enabled&s=4c710e0f36924ef7bcaa6538f74d60444f81c0c9
# 6. Company-Level Activity
https://preview.redd.it/fur3w6jthoqa1.png?width=926&format=png&auto=webp&v=enabled&s=5161684239b968c705ebcff018d5e6b61c48b62b
# 7. Insider-Level Activity
https://preview.redd.it/6t3gm65thoqa1.png?width=931&format=png&auto=webp&v=enabled&s=ffd1bfca92057e8de5209d45c432c816de3d45ae

SCHW president, director, CEO, CFO all bought SCHW when it dipped.
[https://www.dataroma.com/m/stock.php?sym=SCHW](https://www.dataroma.com/m/stock.php?sym=SCHW)
​
//(gpt4 prompt about insider buying)
​
Insider buying refers to the purchase of stock by individuals who have access to non-public information about a company, such as executives or directors. Insider buying is important for stock because it can provide valuable insight into the company's financial health and prospects. If insiders are buying their company's stock, it can be seen as a positive signal that they have confidence in the company's future performance. Conversely, if insiders are selling their stock, it may be seen as a negative signal that they do not have confidence in the company's future prospects. As a result, investors often monitor insider buying and selling activity as part of their investment research process.
​
//(end)

I didn’t realize the Terra CFO was arrested with him. That’s great news, 2 for 1.

How’s that leaky ship:
Skyrocket 12% on the 28th of March and then announce new CFO and project go ahead on the 29th and only rise 3%.
Insider trading or WHAT.

[Lululemon](https://www.ainvest.com/stocks/NASDAQ-LULU/), a Vancouver-based athletic apparel retailer, reported strong holiday-quarter sales with total comparable sales for the fourth quarter increasing by 27%, suggesting that wealthier shoppers are still purchasing yoga pants and tops despite rising prices for essential goods. The company's Q4 revenue rose to $2.77 billion from $2.13 billion a year ago, while earnings per share were $4.40 adjusted compared to $4.26 expected.
[Lululemon](https://www.ainvest.com/stocks/NASDAQ-LULU/)'s CFO, Meghan Frank, stated that the company remains optimistic about delivering sustained growth and long-term value for its stakeholders. Lululemon has projected a higher EPS and revenue for fiscal year 2023 Q1 than what analysts polled by Capital IQ are expecting. Specifically, Lululemon has projected an EPS of $1.93 to $2 on revenue of $1.89 billion to $1.93 billion, while analysts are expecting an EPS of $1.65 and revenue of $1.85 billion. This suggests that Lululemon is expecting to perform better than what analysts are currently anticipating. However, it is important to note that these are just projections, and actual results may differ.
The athletic apparel retailer based in Vancouver, Lululemon, reported a 27% increase in total comparable sales for the fourth quarter. This metric, also known as same-store sales, takes into account sales from stores that have been open continuously for at least 12 months.
​
https://preview.redd.it/68e2gf719nqa1.png?width=452&format=png&auto=webp&v=enabled&s=97dfec154fd77ffe7b5712dd04927e6fc38fb4a8
According to Rick Patel, managing director at Raymond James, Lululemon is one of the few companies in this space that has a long pathway for growth and is highly visible. Patel believes that Lululemon's international business and men's business have upside potential, and the company has already overcome its inventory struggles.
[Lululemon](https://www.ainvest.com/stocks/NASDAQ-LULU/) had reported an 85% increase in inventories at the end of the third quarter in December 2022. However, the company announced that inventories were up 50% at the end of 2022, indicating an improvement in inventory management. Raymond James maintains a strong buy rating on the stock, reflecting confidence in the company's growth potential.
The company's stock rose about 11% in after-hours trading following the report.
Get the latest market information [here](https://www.ainvest.com/).

(hopium-inducing post-Shapella price musing) From the inside, the big deal with respect to the Merge was the September fork: a huge blockchain engineering challenge that could have gone wrong in many ways, that also instantaneously did away with the painfully inflatory generation of millions of new eth per year. Withdrawals, in comparison, looked to be child's play. That is why many of us expected a pump after the September success of the big fork , which, we all know, did not come.
I have been thinking: from the outside, from the perspective of an institutional investor (CFO in charge of the treasury of a traditional company, investment decision maker of a pension fund, family office, whatever), the Merge has \*not\* happened yet. Before withdrawals are live, ether staking is still just a rather iffy black hole, except for trust in the devs and the project development pipeline. We take that trust for granted, but why would a conservative and sceptical investment officer? S/he has to navigate around dozens of questionable projects managed by scam artists, built on hype. Even if eth looks more trustworthy, the doubt remains.
Withdrawals will do away with that, complete the Merge in their eyes as well and make buying and staking eth an option for investors in charge of hundreds of billions of dollars who have not been tempted yet.
We were right, just mistook the timing: the merge pump will come after withdrawals are enabled.

This is…interesting.

No idea what to make of it or whether it means anything.


Michael Kourey - I’d guess that this might be referring to the CFO of Okta of the same name.
RRI Interests - assuming this is the same one, had a lawsuit in 2018…RRI INTERESTS, LLC., vs. DALLAS CENTRAL APPRAISAL DISTRICT
(Def a better source for this stuff, but this link will do for now) https://unicourt.com/case/tx-dl-rri-interests-llc-vs-dallas-central-appraisal-district-239423


That’s…all I got…

Tf, how do they explain the CEO/CFO selling majority of their shares months before retail ever fuckin heard of SVB?